• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

羟氯喹啉离子液体对新型冠状病毒 2 的体外抗病毒活性增强

Enhanced In Vitro Antiviral Activity of Hydroxychloroquine Ionic Liquids against SARS-CoV-2.

作者信息

Faísca Francisco, Correia Vanessa, Petrovski Željko, Branco Luís C, Rebelo-de-Andrade Helena, Santos Miguel M

机构信息

LAQV-REQUIMTE, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal.

Antiviral Resistance Lab, Research & Development Unit, Infectious Diseases Department, Instituto Nacional de Saúde Doutor Ricardo Jorge, IP, Av. Padre Cruz, 1649-016 Lisboa, Portugal.

出版信息

Pharmaceutics. 2022 Apr 17;14(4):877. doi: 10.3390/pharmaceutics14040877.

DOI:10.3390/pharmaceutics14040877
PMID:35456711
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9031298/
Abstract

The development of effective antiviral drugs against SARS-CoV-2 is urgently needed and a global health priority. In light of the initial data regarding the repurposing of hydroxychloroquine (HCQ) to tackle this coronavirus, herein we present a quantitative synthesis and spectroscopic and thermal characterization of seven HCQ room temperature ionic liquids (HCQ-ILs) obtained by direct protonation of the base with two equivalents of organic sulfonic, sulfuric and carboxylic acids of different polarities. Two non-toxic and hydrophilic HCQ-ILs, in particular, [HCQH2][C1SO3]2 and [HCQH2][GlcCOO]2, decreased the virus-induced cytopathic effect by two-fold in comparison with the original drug, [HCQH2][SO4]. Despite there being no significant differences in viral RNA production between the three compounds, progeny virus production was significantly affected (p < 0.05) by [HCQH2][GlcCOO]2. Overall, the data suggest that the in vitro antiviral activities of the HCQ-ILs are most likely the result of specific intra- and intermolecular interactions and not so much related with their hydrophilic or lipophilic character. This work paves the way for the development of future novel ionic formulations of hydroxychloroquine with enhanced physicochemical properties.

摘要

迫切需要开发针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的有效抗病毒药物,这是全球卫生的优先事项。鉴于有关重新利用羟氯喹(HCQ)来应对这种冠状病毒的初步数据,在此我们展示了七种HCQ室温离子液体(HCQ-ILs)的定量合成以及光谱和热表征,这些离子液体是通过用两当量不同极性的有机磺酸、硫酸和羧酸对碱进行直接质子化而获得的。特别是两种无毒且亲水的HCQ-ILs,即[HCQH2][C1SO3]2和[HCQH2][GlcCOO]2,与原始药物[HCQH2][SO4]相比,将病毒诱导的细胞病变效应降低了两倍。尽管这三种化合物在病毒RNA产生方面没有显著差异,但子代病毒产生受到[HCQH2][GlcCOO]2的显著影响(p < 0.05)。总体而言,数据表明HCQ-ILs的体外抗病毒活性很可能是特定分子内和分子间相互作用的结果,与其亲水或亲脂特性关系不大。这项工作为开发具有增强物理化学性质的未来新型羟氯喹离子制剂铺平了道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d31/9031298/65d5a731d128/pharmaceutics-14-00877-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d31/9031298/721639de6e3f/pharmaceutics-14-00877-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d31/9031298/c3ca44b9bda9/pharmaceutics-14-00877-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d31/9031298/82f40769b452/pharmaceutics-14-00877-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d31/9031298/8c85ad82d126/pharmaceutics-14-00877-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d31/9031298/65d5a731d128/pharmaceutics-14-00877-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d31/9031298/721639de6e3f/pharmaceutics-14-00877-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d31/9031298/c3ca44b9bda9/pharmaceutics-14-00877-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d31/9031298/82f40769b452/pharmaceutics-14-00877-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d31/9031298/8c85ad82d126/pharmaceutics-14-00877-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d31/9031298/65d5a731d128/pharmaceutics-14-00877-g004.jpg

相似文献

1
Enhanced In Vitro Antiviral Activity of Hydroxychloroquine Ionic Liquids against SARS-CoV-2.羟氯喹啉离子液体对新型冠状病毒 2 的体外抗病毒活性增强
Pharmaceutics. 2022 Apr 17;14(4):877. doi: 10.3390/pharmaceutics14040877.
2
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates.羟氯喹在非人类灵长类动物中对抗 SARS-CoV-2 感染的应用。
Nature. 2020 Sep;585(7826):584-587. doi: 10.1038/s41586-020-2558-4. Epub 2020 Jul 22.
3
COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.新型冠状病毒肺炎疫情:氯喹和羟氯喹潜在作用的叙事性综述。
Pain Physician. 2020 Aug;23(4S):S351-S366.
4
Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.羟氯喹预防 SARS-CoV-2 感染和妊娠期 COVID-19 疾病严重程度的疗效和安全性(COVID-Preg):一项随机安慰剂对照试验研究方案的结构化总结。
Trials. 2020 Jul 2;21(1):607. doi: 10.1186/s13063-020-04557-y.
5
Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.羟氯喹用于接触新冠病毒疾病(COVID-19)后成年人暴露者预防严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染的暴露后预防效果:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):475. doi: 10.1186/s13063-020-04446-4.
6
Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story.氯喹和羟氯喹治疗 COVID-19:一个永无止境的故事。
Appl Microbiol Biotechnol. 2021 Feb;105(4):1333-1343. doi: 10.1007/s00253-021-11094-4. Epub 2021 Jan 30.
7
Review on the Clinical Pharmacology of Hydroxychloroquine Sulfate for the Treatment of COVID-19.硫酸羟氯喹治疗 COVID-19 的临床药理学综述。
Curr Drug Metab. 2020;21(6):427-435. doi: 10.2174/1389200221666200610172929.
8
An in vitro study of dual drug combinations of anti-viral agents, antibiotics, and/or hydroxychloroquine against the SARS-CoV-2 virus isolated from hospitalized patients in Surabaya, Indonesia.针对从印度尼西亚泗水住院患者中分离出的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒,开展抗病毒药物、抗生素和/或羟氯喹的双药组合体外研究。
PLoS One. 2021 Jun 18;16(6):e0252302. doi: 10.1371/journal.pone.0252302. eCollection 2021.
9
Synthesis and evaluation of enantiomers of hydroxychloroquine against SARS-CoV-2 in vitro.合成并评估了对 SARS-CoV-2 具有体外抑制活性的羟氯喹对映异构体。
Bioorg Med Chem. 2022 Jan 1;53:116523. doi: 10.1016/j.bmc.2021.116523. Epub 2021 Nov 22.
10
Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?补锌能否增强氯喹/羟氯喹的临床疗效,赢得抗击 COVID-19 的今天?
Med Hypotheses. 2020 Sep;142:109815. doi: 10.1016/j.mehy.2020.109815. Epub 2020 May 6.

引用本文的文献

1
Synthesis, characterization and biological activity of methotrexate-derived salts in lung cancer cells.甲氨蝶呤衍生盐类在肺癌细胞中的合成、表征及生物活性
RSC Med Chem. 2025 Apr 16. doi: 10.1039/d4md00960f.
2
Synthesis, Characterization, Bioavailability and Antimicrobial Studies of Cefuroxime-Based Organic Salts and Ionic Liquids.基于头孢呋辛的有机盐和离子液体的合成、表征、生物利用度及抗菌研究
Pharmaceutics. 2024 Oct 2;16(10):1291. doi: 10.3390/pharmaceutics16101291.
3
Synthesis and Behavior of Hexamethylenetetramine-Based Ionic Liquids as an Active Ingredient in Latent Curing Formulations with Ethylene Glycol for DGEBA.

本文引用的文献

1
The role of antiviral treatment in the COVID-19 pandemic.抗病毒治疗在新冠疫情中的作用。
Lancet Respir Med. 2022 Feb;10(2):e18. doi: 10.1016/S2213-2600(22)00011-X. Epub 2022 Jan 13.
2
Etidronate-based organic salts and ionic liquids: In vitro effects on bone metabolism.基于依替膦酸的有机盐和离子液体:对骨代谢的体外影响。
Int J Pharm. 2021 Dec 15;610:121262. doi: 10.1016/j.ijpharm.2021.121262. Epub 2021 Nov 5.
3
SARS-CoV-2 Antiviral Therapy.SARS-CoV-2 抗病毒治疗。
六亚甲基四胺基离子液体的合成与行为作为潜伏固化配方中的活性成分,与乙二醇用于 DGEBA。
Molecules. 2023 Jan 16;28(2):892. doi: 10.3390/molecules28020892.
Clin Microbiol Rev. 2021 Dec 15;34(4):e0010921. doi: 10.1128/CMR.00109-21. Epub 2021 Jul 28.
4
Corrigendum: Getting Through COVID-19: The Pandemic's Impact on the Psychology of Sustainability, Quality of Life, and the Global Economy - A Systematic Review.勘误:《度过新冠疫情:大流行对可持续发展心理学、生活质量和全球经济的影响——一项系统综述》。
Front Psychol. 2021 May 26;12:700815. doi: 10.3389/fpsyg.2021.700815. eCollection 2021.
5
Does hydroxychloroquine still have any role in the COVID-19 pandemic?羟氯喹在 COVID-19 大流行中还有作用吗?
Expert Opin Pharmacother. 2021 Jul;22(10):1257-1266. doi: 10.1080/14656566.2021.1898589. Epub 2021 Mar 16.
6
SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development.SARS-CoV-2 嗜性、进入、复制和传播:药物发现和开发的考虑因素。
PLoS Pathog. 2021 Feb 17;17(2):e1009225. doi: 10.1371/journal.ppat.1009225. eCollection 2021 Feb.
7
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.用于治疗新冠肺炎的抗病毒药物 repurposed - 世界卫生组织团结试验中期结果
N Engl J Med. 2021 Feb 11;384(6):497-511. doi: 10.1056/NEJMoa2023184. Epub 2020 Dec 2.
8
pH-Responsive Nanostructures Based on Surface Active Fatty Acid-Protic Ionic Liquids for Imiquimod Delivery in Skin Cancer Topical Therapy.基于表面活性脂肪酸-质子离子液体的pH响应性纳米结构用于咪喹莫特在皮肤癌局部治疗中的递送
Pharmaceutics. 2020 Nov 11;12(11):1078. doi: 10.3390/pharmaceutics12111078.
9
The Role of Ionic Liquids in the Pharmaceutical Field: An Overview of Relevant Applications.离子液体在制药领域的作用:相关应用概述。
Int J Mol Sci. 2020 Nov 5;21(21):8298. doi: 10.3390/ijms21218298.
10
Specificity and positive predictive value of SARS-CoV-2 nucleic acid amplification testing in a low-prevalence setting.低流行地区 SARS-CoV-2 核酸扩增检测的特异性和阳性预测值。
Clin Microbiol Infect. 2021 Mar;27(3):469.e9-469.e15. doi: 10.1016/j.cmi.2020.10.003. Epub 2020 Oct 14.